| Literature DB >> 29379531 |
Klaudia Suligowska1, Piotr Czarniak2, Michał Krawczyk3, Przemysław Szcześniak2, Ewa Król4, Aida Kusiak5, Robert Sabiniewicz6, Tomasz Wierzba7, Alicja Utracka8, Magdalena Urban9, Anna Wytrykowska9, Anna Pakalska10, Konrad Drewek11, Anna Giczewska12, Piotr Popowski13, Magdalena Wrotkowska14, Joanna Marczulin1, Mariusz Bochniak5, Tomasz Zdrojewski1.
Abstract
INTRODUCTION: The study involved preparing and implementation a model of complex screening programme for adolescents and comparison of anthropometric examinations between the population of the SOPKARD-Junior programme and representative sample of Polish children in the same age.Entities:
Keywords: health assessment survey; health behaviour; prevention; research methods; screening
Year: 2016 PMID: 29379531 PMCID: PMC5778424 DOI: 10.5114/aoms.2016.63742
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Methodology of the laboratory tests
| Test | Specimen | Method | Analyser/manufacturer | Bias (%) | Reproducibility (%) | Repeatability (%) |
|---|---|---|---|---|---|---|
| Serum sodium | Blood/serum | Integrated Chip Technology (ICT) | Architect c8000/Abbott Laboratories | 0.65 | 0.26 | 1.08 |
| Urinary sodium | Urine portion | Integrated Chip Technology (ICT) | Architect c8000/Abbott Laboratories | –2.05 | 0.49 | 1.03 |
| Serum potassium | Blood/serum | Integrated Chip Technology (ICT) | Architect c8000/Abbott Laboratories | 1.6 | 1.00 | 2.305 |
| Urinary potassium | Urine portion | Integrated Chip Technology (ICT) | Architect c8000/Abbott Laboratories | –2.5 | 1.11 | 1.25 |
| TSH | Blood/serum | Chemiluminescent microparticle immunoassay (CMIA) | Architect I2000/Abbott Laboratories | –3.8 | 2.35 | 6.37 |
| Serum creatinine | Blood/serum | Enzyme-based method | Architect c8000/Abbott Laboratories | –1.9 | 0.92 | 2.61 |
| Urinary creatinine | Urine portion | Enzyme-based method | Architect c8000/Abbott Laboratories | 10.1 | 1.86 | 2.2 |
| Triglycerides | Blood/serum | Glycerol phosphate oxidase | Architect c8000/Abbott Laboratories | –4.7 | 0.79 | 1.83 |
| HDL cholesterol | Blood/serum | Selective Detergent accelerator | Architect c8000/Abbott Laboratories | –8.7 | 1.9 | 2.94 |
| LDL cholesterol | Blood/serum | Calculated from the Friedewald formula | ||||
| Total cholesterol | Blood/serum | Enzyme-based method | Architect c8000/Abbott Laboratories | –0.28 | 0.55 | 1.5 |
| Urea nitrogen | Blood/serum | Urease method | Architect c8000/Abbott Laboratories | 3.05 | 0.64 | 2.58 |
| Urinary albumin | Urine portion | Immunoturbidimetry | Architect c8000/Abbott Laboratories | 8.5 | 1.17 | 4.14 |
| Cystatin C | Blood/serum | Immunonephelometry | BN II /Siemens Healthcare | 9.6 | 1.19 | 1.8 |
| CRP (C-reactive protein) | Blood/serum | Immunoturbidimetry | Architect c8000/Abbott Laboratories | 2.8 | 2.18 | 3.34 |
| Uric acid | Blood/serum | Uricase | Architect c8000/Abbott Laboratories | 5.58 | 1.07 | 2.04 |
| Glucose | Blood/plasma | Hexokinase/G6PD | Architect c8000/Abbott Laboratories | –1.84 | 1.34 | 1.8 |
| Peripheral blood count | Whole blood | |||||
| White blood cell count (WBC) | Fluorescence flow cytometry using a semiconductor laser | XE-2100/Sysmex | –5.39 | 1.04 | 1.6 | |
| Red blood cell count (RBC) | Impedance method with hydrodynamic focusing | 0.62 | 0.47 | 0.43 | ||
| Haemoglobin (HGB) | Absorptive photometry using sodium lauryl sulfate (a non-cyanide method) | 0.79 | 0 | 0.51 | ||
| Platelet count (PLT) | Impedance method with hydrodynamic focusing | –7.44 | 2.96 | 1.09 | ||
| Urinalysis | Urine portion | iChemVelocity Strips dipstick tests | IRICELL/Beckman Coulter |
Comparison of the results of anthropometric examination with blood pressure measurement between the adolescents participating in the SOPKARD programme and the adolescents participating in the OLAF programme
| Parameter | Boys | Statistical significance | Girls | Statistical significance | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOPKARD | OLAF | SOPKARD | OLAF | |||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||
| Height [cm] | 173.41 | 5.53 | 169.8 | 5.6 | < 0.0001 | 163.49 | 5.00 | 162.98 | 4.27 | 0.2624 |
| Body mass [kg] | 63.57 | 8.58 | 58.38 | 8.51 | < 0.0001 | 57.91 | 8.66 | 53.92 | 6.85 | < 0.0001 |
| BMI [kg/m2] | 21.06 | 2.53 | 20.07 | 2.43 | < 0.0001 | 21.57 | 2.72 | 20.24 | 2.29 | < 0.0001 |
| Waist circumference [cm] | 75.82 | 6.79 | 71.3 | 5.58 | < 0.0001 | 72.35 | 7.92 | 67.83 | 4.81 | < 0.0001 |
| Hip circumference [cm] | 91.18 | 5.98 | 88.67 | 5.54 | < 0.0001 | 91.53 | 6.38 | 90.67 | 4.99 | 0.1372 |
Data on the number and percentage of children included in the SOPKARD programme who completed a specified assessment in 2013 and 2014
| Examination | Number of subjects | Percentage of all eligible subjects |
|---|---|---|
| Anthropometric examination | 268 | 95 |
| Blood pressure assessment | 268 | 95 |
| Echocardiographic assessment | 133 | 47 |
| Electrocardiographic assessment | 153 | 100 |
| Ultrasound assessment (of the kidneys, thyroid and carotid arteries) | 150 | 54 |
| Spirometry and assessment of exhaled nitric oxide concentration | 242 | 86 |
| Dental check-up with a particular emphasis on the periodontium | 266 | 94 |
| Masticatory system assessment | 115 | 89 |
| Orthopaedic assessment | 99 | 77 |
| Psychological and psychiatric assessment | 265 | 94 |
| Blood and urine tests | 251 | 89 |
| Programme quality assessment | 104 | 81 |
Assessment performed only in 2013
Assessment performed only in 2014